CRMD Q4 2023 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$53,507

Operating Income

-$16M

Net Income

-$15M

EPS (Diluted)

$-0.26

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$82M

Total Liabilities

$12M

Stockholders' Equity

$70M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$29,702	-100.0%
Gross Profit	-$53,507	$29,296	-282.6%
Operating Income	-$16M	-$8M	-86.8%
Net Income	-$15M	-$8M	-79.7%